Related Experiment Video
Updated: Jun 19, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Serum levels of the adipokine chemerin in relation to renal function
Dörte Pfau1, Anette Bachmann, Ulrike Lössner
1Department of Internal Medicine III, University of Leipzig, Leipzig, Germany.
Insights
Serum chemerin levels are significantly elevated in patients undergoing chronic hemodialysis (CD) compared to controls. Glomerular filtration rate (GFR) independently predicts these higher chemerin levels in both groups.
Area of Science:
- Nephrology
- Endocrinology
- Biochemistry
Background:
- Chemerin is an adipokine implicated in metabolic and inflammatory processes.
- Chronic kidney disease (CKD) is associated with altered levels of various adipokines.
Purpose of the Study:
- To compare serum chemerin levels in patients on chronic hemodialysis (CD) with healthy controls.
- To investigate the relationship between chemerin levels and renal function, glucose/lipid metabolism, and inflammation.
Main Methods:
- Serum chemerin was quantified using ELISA in CD patients (n=60) and controls (n=60).
- Correlations were analyzed with clinical and biochemical parameters, including glomerular filtration rate (GFR).
Main Results:
- Serum chemerin levels were more than twofold higher in CD patients (542.2 microg/l) versus controls (254.3 microg/l) (P < 0.001).
- GFR independently predicted circulating chemerin concentrations in both patient groups (P < 0.05 for controls, P < 0.01 for CD patients).
Conclusions:
- Markers of renal function are independently associated with circulating chemerin levels.
- Chemerin may play a role in the pathophysiology of chronic kidney disease and its complications.
Objective:
To investigate serum levels of the adipokine chemerin in patients on chronic hemodialysis (CD) as compared with control patients with a glomerular filtration rate (GFR) >50 ml/min.
Research Design And Methods:
Chemerin was quantified by ELISA in control patients (n = 60) and CD patients (n = 60) and correlated with clinical and biochemical measures of renal function, glucose, and lipid metabolism, as well as inflammation, in both groups.
Results:
Median serum chemerin levels were more than twofold higher in CD patients (542.2 microg/l) compared with subjects with a GFR >50 ml/min (254.3 microg/l) (P < 0.001). Furthermore, GFR, as assessed by the original Modification of Diet in Renal Disease formula, independently predicted circulating chemerin concentrations in multiple regression analyses in both control patients (P < 0.05) and CD patients (P < 0.01).
Conclusions:
We demonstrate that markers of renal function are independently related to circulating chemerin levels.
Related Concept Videos
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
